日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting the ERα DBD-LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation.

利用米托蒽醌靶向 ERα DBD-LBD 界面,通过蛋白酶体降解破坏受体功能。

Wang Han, Luo Yuxuan, Artham Sandeep, Wang Qianqian, Peng Yi, Yun Zixi, Li Xinyue, Wu Chen, Liu Zhenghao, Weber-Bonk Kristen L, Pai Chun-Peng, Cao Yuan, Yue Jiangan, Park Sunghee, Keri Ruth A, Geng Lisheng, McDonnell Donald P, Kao Hung-Ying, Yang Sichun

Exploiting YES1-Driven EGFR Expression Improves the Efficacy of EGFR Inhibitors.

利用 YES1 驱动的 EGFR 表达可提高 EGFR 抑制剂的疗效

Cuellar-Vite Leslie, Donaubauer Elyse M, Weber-Bonk Kristen L, Bobbitt Jessica R, Ingles Natasha N, Brzozowski Taylor L, Abdul-Karim Fadi W, Booth Christine N, Keri Ruth A

Targeting YES1 Disrupts Mitotic Fidelity and Potentiates the Response to Taxanes in Triple-Negative Breast Cancer.

靶向 YES1 可破坏有丝分裂的保真度,并增强三阴性乳腺癌对紫杉烷类药物的反应

Piemonte Katrina M, Ingles Natasha N, Weber-Bonk Kristen L, Valentine Mitchell J, Majmudar Parth R, Singh Salendra, Keri Ruth A